NCT02469454

Effect of t of the Etonogestrel Releasing Implant on Infant Growth and Development

Effect of the Immediately Postpartum Insertion of the Etonogestrel Releasing Implant on Infant Growth and Development

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: University of Sao Paulo · Academic / Other
• Sex: Female
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

This study aims to assess whether there is change in the growth and development of newborns whose mothers will have a etonogestrel (ENG) releasing implant inserted in the first 24 to 48 hours of delivery compared with those with standard implant insertion (6 week postpartum).

Conditions

• Contraception
• Newborn
• Child Development
• Growth

Interventions

Type	Name	Description
DRUG	early insertion	Postpartum women into whom the etonogestrel-releasing contraceptive implant (Implanon®, N.V. Organon, Oss, Netherlands) will be inserted in the first 48 h postpartum.
DRUG	conventional insertion	Postpartum women into whom the etonogestrel-releasing contraceptive implant (Implanon®, N.V. Organon, Oss, Netherlands) will be inserted in the first 6 week of delivery.

Timeline

• Start date: 2015-06-01
• Primary completion: 2016-08-01
• Completion: 2016-09-01
• First posted: 2015-06-11
• Last updated: 2016-11-03

Locations

1 site across 1 country: Brazil